Media Statement: Tracking mutations of the SARS CoV2

We have been regularly tracking mutations of the virus throughout the pandemic to determine the impact it would have on our PCR sensitivity. To date, we have not seen any impact. Our current capacity for PCR tests is 270k and we continue to operate with a 1-2 day turnaround. The only way to identify the strain is by sequencing, and we have research support underway that includes sequencing of the virus.

Labcorp to announce fourth quarter and full year 2020 financial results on February 11, 2021

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 8, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, will release its fourth quarter and full year 2020 financial results before the market opens on Thursday, Feb. 11, 2021 , and then will host a conference call and webcast beginning at 9:00 a.m. ET to discuss the results. 

Labcorp awarded CDC contract to study variants of COVID-19 virus and improve public health response

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 7, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has been awarded a contract from the Centers for Disease Control and Prevention ( CDC ) to provide genomic sequencing of samples of SARS-CoV-2, the virus that causes COVID-19.

Brian Caveney, chief medical officer and president of Labcorp Diagnostics, named to Modern Healthcare's 100 Most Influential People in Healthcare

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 6, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that Dr. Brian Caveney, chief medical officer and president of Labcorp Diagnostics , was recognized by Modern Healthcare as one of the 100 most influential people in healthcare in 2020.

Labcorp is scheduled to virtually participate at the 39th annual J.P. Morgan Healthcare conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 5, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a virtual fireside chat at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 12 at 8:20 a.m. (EST).

Walgreens and Labcorp make Pixel by Labcorp™ at-home COVID-19 collection kit available through Walgreens Find Care®

DEERFIELD, Ill. & BURLINGTON, N.C. --(BUSINESS WIRE)--Dec. 21, 2020-- Labcorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, and Walgreens today announced that the Pixel by Labcorp™ At-Home COVID-19 Collection Kit is now available from Labcorp through Walgreens Find Care®, a digital health platform available on the Walgreens app and Walgreens.com. Walgreens currently offers COVID-19 testing in more than 1,100 drive-thru locations across the country.

Labcorp and Rush University System for Health enter into a partnership focused on laboratory, clinical trial and data service

Labcorp now serves as the primary lab for the RUSH network as it embarks on a comprehensive clinical trials relationship Labcorp (NYSE: LH) has entered into a comprehensive partnership with Rush University System for Health (RUSH) to serve as the primary lab for Chicago-based hospitals and physicians in the RUSH network. RUSH will also operate as a site partner for clinical trials through Labcorp’s drug development business, Covance. Together, Labcorp’s diagnostics and drug development expertise, along with RUSH’s deep roots in integrated, academic medicine, will enable scientific innovations and new care options for the communities RUSH serves.

Labcorp evolves its brand to showcase its role as a trusted source in healthcare

BURLINGTON, N.C., Dec. 16, 2020 — Labcorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, is evolving its brand identity to highlight the pivotal role the company plays in healthcare and showcase the power of the company’s diagnostic and drug development offerings. Labcorp started as a diagnostics company over 50 years ago. Today, it employs over 70,000 people worldwide and impacts more than 160 million lives annually through diagnostic insights and the development of innovative, life-changing treatments. 

LabCorp receives FDA authorization to make at-Home COVID-19 collection kits available through retail

Pixel by LabCorp™ COVID-19 Test Home Collection Kit is first to receive FDA authorization for over-the-counter purchase BURLINGTON, N.C. --(BUSINESS WIRE)--Dec. 9, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care